Criscitiello, Carmen <br/><br/>
Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment.  [electronic resource] 

 -  Cancer treatment reviews  Feb 2015 
 - 61-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-1967 
<br/><br/><label>Standard No.: </label>10.1016/j.ctrv.2014.12.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Bone Density Conservation Agents--pharmacology<br/>Bone Diseases--immunology<br/>Bone Neoplasms--drug therapy<br/>Bone Remodeling--immunology<br/>Bone Resorption--immunology<br/>Bone and Bones--immunology<br/>Clodronic Acid--pharmacology<br/>Denosumab<br/>Diphosphonates--pharmacology<br/>Humans<br/>Ibandronic Acid<br/>Imidazoles--pharmacology<br/>Immune System<br/>Osteoclasts--drug effects<br/>Osteoprotegerin--drug effects<br/>Pamidronate<br/>RANK Ligand--antagonists & inhibitors<br/>Receptor Activator of Nuclear Factor-kappa B--drug effects<br/>Signal Transduction--drug effects<br/>Treatment Outcome<br/>Zoledronic Acid